本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Lantern Pharma Inc.

1.71
-0.0500-2.84%
盤後1.710.00000.00%19:30 EDT
成交量:10.98萬
成交額:19.13萬
市值:2,181.77萬
市盈率:-1.05
高:1.82
開:1.78
低:1.70
收:1.76
52周最高:4.70
52周最低:1.11
股本:1,275.89萬
流通股本:1,013.96萬
量比:0.57
換手率:1.08%
股息:- -
股息率:- -
每股收益(TTM):-1.6362
每股收益(LYR):-1.5709
淨資產收益率:-400.92%
總資產收益率:-74.29%
市淨率:-6.78
市盈率(LYR):-1.09

資料載入中...

2024/06/07

SEC問詢函

Form CORRESP - Correspondence
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/24

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/18

重要事件披露

Form 8-K - Current report
2024/03/18

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/01

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/29

重要事件披露

Form 8-K - Current report
2023/12/01

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/25

重要事件披露

Form 8-K - Current report